IP Library Granted Patent US 8,076,462
Granted Patent B2
US 8,076,462 · App. 12/594,423 · Granted Dec 13, 2011

Method for producing antithrombin composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,462
App. No.
12/594,423
Granted
Dec 13, 2011
Kind
B2
Abstract

The provision of an antithrombin composition having a desired α-form content rate or β-form content rate is required. The invention provides a process for producing an antithrombin composition having a desired α-form content rate or β-form content rate which is prepared by contacting an antithrombin-containing aqueous solution with a Cellufine Sulfate chromatography carrier.

Claims (22)

1. A process for producing an antithrombin composition, comprising

contacting an antithrombin-containing aqueous solution with a cellulose sulfate ester chromatography carrier to obtain an antithrombin composition comprising antithrombin with an α-form content rate of at least 80%; and

eluting the antithrombin compositions from a fraction adsorbed onto the carrier with an eluent having a conductivity of 0.01 mS/cm to 50 mS/cm to obtain an eluate with the antithrombin composition.

2. The process according to claim 1 , which further comprises carrying out anion exchange chromatography and/or hydrophobic chromatography.

3. The process according to claim 2 , wherein the hydrophobic chromatography is carried out after the cellulose sulfate ester chromatography.

4. The process according to claim 1 ,

(a) wherein the antithrombin composition comprises an antithrombin in which sugar chains bound to the antithrombin contained in the composition have 1 or more to 3 or less sialic acids in average per sugar chain; or

(b) wherein the antithrombin composition comprises an antithrombin in which sugar chains bound to the antithrombin contained in the composition have 1.5 or more to 2.5 or less sialic acids in average per sugar chain.

5. The process according to claim 4 , wherein the sugar chains bound to the antithrombins are 3 or 4 sugar chains.

6. The process according to claim 1 , wherein the antithrombin in the antithrombin composition has 3 or more to 12 or less sialic acids in average per antithrombin molecule.

7. The process according to claim 1 , wherein the antithrombin in the antithrombin composition has 6 or more to 8 or less sialic acids in average per antithrombin molecule.

8. A process for producing an antithrombin composition, comprising contacting a conductivity-adjusted antithrombin-containing aqueous solution with a cellulose sulfate ester chromatography carrier to obtain an antithrombin composition comprising antithrombin with an α-form content rate of at least 80% from a fraction unadsorbed onto the carrier, and

collecting the antithrombin composition from the fraction unadsorbed onto the carrier,

wherein the conductivity-adjusted antithrombin-containing aqueous solution has a conductivity of 0.1 mS/cm to 50 mS/cm.

9. The process according to claim 8 , which further comprises carrying out anion exchange chromatography and/or hydrophobic chromatography.

10. The process according to claim 9 , wherein the hydrophobic chromatography is carried out after the cellulose sulfate ester chromatography.

11. The process according to claim 8 ,

(a) wherein the antithrombin composition comprises an antithrombin in which sugar chains bound to the antithrombin contained in the composition have 1 or more to 3 or less sialic acids in average per sugar chain; or

(b) wherein the antithrombin composition comprises an antithrombin in which sugar chains bound to the antithrombin contained in the composition have 1.5 or more to 2.5 or less sialic acids in average per sugar chain.

12. The process according to claim 11 , wherein the sugar chains bound to the antithrombins are 3 or 4 sugar chains

13. The process according to claim 8 , wherein the antithrombin in the antithrombin composition has 3 or more to 12 or less sialic acids in average per antithrombin molecule.

14. The process according to claim 8 , wherein the antithrombin in the antithrombin composition has 6 or more to 8 or less sialic acids in average per antithrombin molecule.

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2009
From: SUGIHARA, TSUTOMU; ONODERA, SETSUKO; URAKUBO, TOMONARI; SUZAWA, TOSHIYUKI
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 023320/0362 →